Project Grant HT94252410623
Award Date 8/1/24
Completion Date 8/31/26
Dollars Obligated $603K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- The University of Pittsburgh was awarded a $1,005,056 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to target MYCN in pediatric high-grade gliomas using combinatorial approaches. Through this award, the University of Pittsburgh will investigate medical solutions for childhood brain cancers affecting military families and the general...
- The University of Pittsburgh has been awarded a $681,379 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to evaluate B-T cell cross talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The award has a performance period from July 1, 2024 to June 30, 2027. This research project aims to enhance understanding of the immune processes involved in melanoma development and response to...
- The University of Pittsburgh received a $726,989 Project Grant awarded September 15, 2025, by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct immunotherapeutic research targeting SLC39A9 in CDKN2A-low melanoma. The three-year award, with an ultimate completion date of September 14, 2028, supports research and development activities designed to advance innovative medical solutions for cancer treatment. The research will be conducted...
- The University of Pittsburgh was awarded a $795,001 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will fund a research project from September 2022 to August 2025 to interrogate the impact of B cells and tertiary lymphoid structures in melanoma brain metastases. Through this funding, the University of Pittsburgh will investigate medical solutions for the battlefield by supporting applied and advanced...
- This $846,182 Project Grant award to the University of Pittsburgh was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "INTRAGENIC REARRANGEMENT BURDEN AS A GENOMIC PREDICTOR OF IMMUNOTHERAPY BENEFIT IN TRIPLE-NEGATIVE BREAST CANCER" with a performance period from Aug 1, 2024 to Jul 31, 2027. As a major research university, the University of Pittsburgh will leverage its extensive...
- This Project Grant award, worth $647,861.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The funding will support a 3-year research project evaluating the interplay between B-cells and T-cells within the tumor microenvironment of melanoma, and the impact on immune checkpoint blockade therapies. The University of Pittsburgh, a major recipient of federal biomedical research grants, will...
- This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
- Federal Grant Award Summary The University of Pittsburgh received a $434,722 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with an ultimate completion date of August 14, 2029. The grant supports "A Collaborative Multiomic Approach to Pediatric Scleroderma" (CMAPS), a research initiative designed to molecularly characterize and stratify pediatric scleroderma patients. This four-year...
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.18 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, through August 31, 2028. This award supports research focused on overcoming immunotherapy resistance in acral melanoma, a specialized oncology research initiative aligned with the Defense Health Agency's mission to advance biomedical solutions for Service...
- Federal Grant Award Summary The University of Pittsburgh received a $673,197 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 15, 2025, through August 14, 2027. The award supports research focused on harmonization of severe traumatic brain injury (TBI) multiomic analyses within the BioBoost and BioHobit research initiatives. This project delivers biomedical research services designed to advance...